Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: Relationship to body composition and IL-1 α and β plasma levels

Pharmacological Research

Volumn 55, Issue 2, 2007, Pages 131-138

  Di Renzo, Laura ^a,b   Bigioni, Mario ^a   Del Gobbo, Vera ^a   Premrov, Maria Grazia ^a   Barbini, Ugo ^a   Di Lorenzo, Nicola ^a,c   De Lorenzo, Antonino ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INDiM   (Italy)

^c Fondazione Salus Onlus   (Italy)

Author keywords

Body fat mass; IL 1 ; IL 1 ; IL 1 Ra gene; NWO

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ALLELE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; TANDEM REPEAT;

ADULT; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DENSITOMETRY, X-RAY; DNA; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 33846574357     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.11.002     Document Type: Article

References (35)

1. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
2. Cybulsky M.I., and Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251 (1991) 788-791
3. Cybulsky M.I., and Gimbrone Jr. M.A. Scavanger receptors in innate immunity. Curr Opin Immunol 14 (2002) 123-128
4. Janeway C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
5. Lennard A., Gorman O., Carrier M., Griffiths S., Scotney H., Sheer D., et al. Cloning and chromosome mapping of human interleukin-1 receptor antagonist gene. Cytokine 4 (1992) 83-89
6. Freeman B.D., and Buchman T.G. Interleukin-1 receptor antagonist as therapy for inflammatory disorders. Expert Opin Biol Ther 1 (2001) 301-308
7. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91 (1993) 403-404
8. Seripa D., Dobrina A., Margaglione M., Matera M.G., Gravina C., and Vecile E. Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc Dis 15 (2003) 276-281
9. Riha R.L., Yang I.A., Rabnott G.C., Tunnicliffe A.M., Fong K.M., and Zimmerman P.V. Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Intern Med J 34 (2004) 126-129
10. Palli D., Saieva C., Luzzi I., Masala G., Topa S., Sera F., et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 9 (2005) 941-1948
11. Um J.Y., Lee K.M., and Kim H.M. Polymorphism of interleukin-1 receptor antagonist gene and obesity. Clin Chim Acta 340 (2004) 173-177
12. Ahima R.S. Central actions of adipocyte hormones. Trends Endocrinol Metab 16 (2005) 307-313
13. Dong C., Li W.D., Geller F., Lei L., Li D., Gorlova O.Y., et al. Possible genomic imprinting of three human obesity-related genetic loci. Am J Hum Genet 76 (2005) 427
14. Chen H. Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol Res 53 6 (2006 Jun) 469-477
15. Al Suwaidi J., Higano S.T., Holmes D.R., Lennon R., and Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 37 (2001) 1523-1528
16. De Lorenzo A., Martinoli R., Vaia F., and Di Renzo L. Normal weight obese (NWO) women: an evaluation of candidate new syndrome. Nutr Metabol Cardiovasc Dis 16 (2006) 513-523
17. Di Renzo L., Del Gobbo V., Bigioni M., Premrov M.G., Cianci R., and De Lorenzo A. Body composition analyses in normal weight obese women. Eur Rev Med Pharmacol Sci 10 July-August (4) (2006) 191-196
18. Grundy S.M.G., Brewer B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome. Circulation 109 (2004) 433-438
19. Karelis A.D., St-Pierre D.H., Conus F., Rabasa-Lhoret R., and Poehlman E.T. Metabolic and body composition factors in subgroups of obesity: what do we know?. J Clin Endocrinol Metab 89 (2004) 2569-2575
20. Karelis A.D., Faraj M., Bastard J.P., St-Pierre D.H., Brochu M., Prud'homme D., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin End Metabol 90 7 (2005) 4145-4150
21. Diet, nutrition and the prevention of chronic diseases. Word Health Organ Tech Rep Ser 2003; 916:1-149.
22. Lohman T.G., Roche A.F., and Martorell R. Anthropometric standardization reference manual (1998), Human Kinetics, Champaing, IL p. 121-33
23. De Lorenzo A., Andreoli A., and Candeloro N. Within-subject variability in body composition using dual-energy X-ray absorptiometry. Clin Physiol 17 (1997) 383-384
24. Guo Y.P., Franks W., Brookshire T., and Tataranni P.A. The intra- and inter-instrument reliability of DXA based on ex vivo soft tissue measurements. Obes Res 12 (2004) 1925-1929
25. Tseng L.H., Chen P.J., Lin M.T., et al. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 57 (2001) 318-324
26. Smith S.R., and Ravussin E. Genetic and physiological factors in obesity. J La State Med Soc 157 (2005) 12-18
27. Bell C.G., Walley A.J., and Froguel P. The genetics of human obesity. Nat Rev Genet 6 (2005) 221-234
28. Liu Y.J., Xiao P., Xiong D.H., Recker R.R., and Deng H.W. Searching for obesity genes: progress and prospects. Drugs Today 41 (2005) 345-362
29. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) 745-751
30. Roux-Lombard P. The interleukin-1 family. Eur Cytokine Netw 9 (1998) 565-576
31. Sciacca F.L., Canal N., and Grimaldi L.M. Induction of IL-1 receptor antagonist by interferon beta: implication for the treatment of multiple sclerosis. J Neurovirol 6 (2000) 33-37
32. Santtila S., Savinainen K., and Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1 β production in vitro. Scand J Immunol 47 (1998) 195-198
33. Machado J.C., Pharoah P., Sousa S., Carvalho R., Oliveira C., Figueiredo, et al. Interleukin 1β and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 (2001) 823-829
34. Ruderman N., Chisholm D., Pi-Suneir X., and Schneider S. The metabolically obese normal weight revisited. Diabetes 47 (1998) 699-713
35. A De Lorenzo, V Del Gobbo, M G Premrov, M Bigioni, F Galvano, L Di Renzo. Normal weight obese syndrome: an early inflammation? Am J Clin Nutr, in press.